<DOC>
	<DOCNO>NCT00692588</DOCNO>
	<brief_summary>Objectives : To study change brain structure function use MRI scan patient treat Alzheimer 's disease . Methods : A pilot study treat Alzheimer 's disease antibiotic show promise treatment could delay deterioration mind disease . This study replicate large scale , provide definitive answer question . In addition look change mind ( cognitive test ) , would like use MRI scan patient treatment study structural change chemical change brain . This would provide non-invasive look bran process protect brain effect Alzheimer 's well confirm disease modify treatment . Impact : The novel treatment Alzheimer 's antibiotic provide potential breakthrough field . In addition verifying change brain , MRI scan observe HOW process could occur , thus open door new treatment Alzheimer 's perhaps even cure .</brief_summary>
	<brief_title>MRI Measure Treatment With Antibiotics Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>( DARAD Trial ) 1 . Male female age 50 year old . 2 . Diagnosis dementia use standardized DSM IV criterion probable Alzheimer 's disease ( NINCDSADRDA criterion ) . 3 . SMMSE score 1426 inclusive . 4 . Patients consistent caregiver accompany clinic visit , ensure medication compliance , monitor report adverse event sign inform consent participation . 5 . Sufficient visual , hear communication skill complete standardize test English . 6 . Patients legally acceptable representative personal care sign inform consent . 7 . Otherwise healthy physical examination screen physical laboratory testing . ( DARAD Trial ) 1 . Patients neurodegenerative disease Lewy Body dementia , Parkinson 's disease , Frontotemporal Dementia , Huntington 's Chorea , Down 's Syndrome Creutzfeld Jacob Disease . 2 . Cognitive impairment may due follow condition : 1. acute cerebral trauma , subdural hematoma , injuries chronic trauma like box . 2 . Hypoxic cerebral damage e.g . post cardiac arrest , postanesthesia etc . 3 . Vitamin deficiency like B12 deficiency treat stabilized one month patient randomize study . Patients take B12 one month include study . 4 . Infections like cerebral abscess , herpes , neurosyphilis , meningitis AIDS . 5 . Primary metastatic cerebral neoplasia . 6 . Endocrine deficiency like hypercalcemia , hypothyroidism , hyperparathyroidism , Cushing 's syndrome , severe renal failure , poorly control diabetes mellitus , pituitary disease , etc . 7 . Mental retardation . If patient one condition opinion investigator condition stabilize contribute decline cognition patient may include study steer committee review situation approve participation . 3 . Multiinfarct dementia significant cerebrovascular disease evidence ) stroke deficit may confound assessment cognitive function b ) multiple focal sign exam indicative multiple ischemic event c ) finding CT MRI scan show multiple lacunar infarct , extensive periventricular white matter lesion , infarct angular gyrus , thalamus , basal forebrain , anterior posterior cerebral artery territory . 4 . Patients significant intracranial pathology tumour hydrocephalus confirm CT MRI past two year . The CT MRI must repeat inclusion patient experience significant loss consciousness neurological sign symptom , stepwise deterioration sustain significant head injury since last scan perform . Patients loss consciousness , transient ischemic attack drop attack , may consider occur precede twelve month . 5 . Patients follow coexist medical condition : 1 . History epilepsy convulsion . 2 . Clinically significant psychiatric condition ( base DSMIV criterion ) like major depression , schizophrenia . A Cornell Scale Depression Dementia score 12 38 . 3 . Moderate severe behavioural disturbance , 4 . Clinically significant hepatic , renal , pulmonary , metabolic endocrine disease . 5 . History drug alcohol abuse year prior enrolment . 6 . History myasthenia gravis . 6 . Clinically significant cardiac disease : 1 . Cardiac surgery past six month . 2 . Unstable angina poorly control congestive heart failure ( NYHA III IV ) . 3 . Uncontrolled hypertension systolic pressure great 180 mmHg . diastolic pressure great 110 mmHg . 7 . Patients take antidementia treatment follow exception : donepezil , galantamine , rivastigmine , memantine , ASA 650 mg OD , Vitamin E 400 i.u. , multi B vitamin , Ginko biloba , Cox II inhibitor statin . In case dose stable three month , expect change duration trial . 8 . Patients enrol clinical trial investigational drug . 9 . Patients take long term antibiotic ( one month past six month ) . 10 . Allergies antibiotic . ( MRI ) 1 . Cardiac pacemaker implantable defibrillator 2 . Cerebral aneurysm clip 3 . Neural stimulator ( e.g . TENSUnit ) 4 . Any type ear implant 5 . Ocular foreign body ( e.g . metal shaving ) 6 . Any implanted device ( e.g . insulin pump , drug infusion device ) 7 . Metal shrapnel bullet .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>Diffusion Tensor Imaging</keyword>
	<keyword>Susceptibility Weighted Imaging</keyword>
	<keyword>Doxycycline</keyword>
	<keyword>Rifampicin</keyword>
</DOC>